C-BRAIN and NVIDIA Use AI to Accelerate Alzheimer’s Research by Unlocking Dark Data
The Consortium for Biomedical Research and AI in Neurodegeneration (C‑BRAIN), a coalition of 18 academic, philanthropic, pharmaceutical and research institutions, has partnered with NVIDIA to build an AI‑driven platform that aggregates previously inaccessible Alzheimer’s data—unpublished findings, negative results and proprietary datasets—into a hybrid centralized/federated system. The platform runs 64 NVIDIA data‑center GPUs on‑premises and additional cloud nodes on Microsoft Azure, with plans to add NVIDIA Blackwell GPUs. By training models on data that never leaves each institution’s secure environment, C‑BRAIN aims to reduce the time for researchers to analyze complex datasets from weeks to hours, thereby speeding the discovery of new treatments for the 57 million people worldwide living with dementia.
The initiative demonstrates how AI can break down data silos and dramatically accelerate biomedical research, a development that matters to anyone following advances in AI, medical science, and the future of drug discovery.
Source: NVIDIA Blog · blogs.nvidia.com